Metacrine IncOTC Pink - Current Information:MTCR
- LAST PRICE0.5706
- TODAY'S CHANGE (%)0.0006 (0.1053%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.5700 / 0.5700
- Day Range
- 52 Week Range
- Volume121,283
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MTCR |
|---|---|---|
| 10:12 ET | 26400 | 0.57495 |
| 10:14 ET | 23600 | 0.57 |
| 10:32 ET | 250 | 0.57 |
| 10:37 ET | 500 | 0.57 |
| 10:42 ET | 250 | 0.57 |
| 10:46 ET | 20000 | 0.57185 |
| 10:51 ET | 250 | 0.5707 |
| 10:53 ET | 20000 | 0.57 |
| 11:09 ET | 450 | 0.5712 |
| 11:18 ET | 251 | 0.57 |
| 11:33 ET | 324 | 0.57 |
| 11:42 ET | 500 | 0.57 |
| 11:44 ET | 500 | 0.57 |
| 12:43 ET | 100 | 0.57 |
| 01:55 ET | 1000 | 0.57 |
| 01:57 ET | 24600 | 0.5725 |
| 02:26 ET | 1500 | 0.575 |
| 03:09 ET | 500 | 0.57 |
| 03:32 ET | 178 | 0.5706 |
Mar 24, 2023
Mar 3, 2023
BRIEF-Metacrine Inc Common Stock Will Be Delisted From Nasdaq, from 5:31PM ET on Friday Mar 03, 2023 by Thomson Reuters
5:31PM ET on Friday Mar 03, 2023 by Thomson Reuters
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Metacrine Inc | 25.0M | -0.6x | --- |
Addex Therapeutics Ltd | 22.7M | 0.0x | --- |
Immix Biopharma Inc | 25.3M | -0.5x | --- |
Lisata Therapeutics Inc | 25.5M | -0.3x | --- |
Tempest Therapeutics Inc | 24.5M | -0.7x | --- |
TFF Pharmaceuticals Inc | 24.8M | -0.5x | --- |
Company Information
Metacrine, Inc. is a United States-based biotechnology company. The Company is engaged in developing therapeutics for metabolic diseases. The Company leverages approximately two mechanistically distinct programs to target type 2 diabetes, NASH and other metabolic diseases and liver disorders. The Company focuses on advancing research in nuclear hormone receptors for treatment of metabolic diseases.
Contact Information
- Headquarters
- 4225 Executive Square, Suite 600SAN DIEGO, CA, United States 92037
- Phone
- 858-369-7800
- Fax
- 858-369-7801
Executives
- President, Chief Executive Officer, Treasurer, Secretary
- Dave Maggio
- Director
- H. Michael Hogan
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $25.0M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 43.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.90 |
Book Value | $1.36 |
P/E Ratio | -0.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
